State Settles With Stryker Biotech For $1.35 Million

Bizjournals -- The state attorney general’s office has settled with Stryker Biotech LLC over allegations the company improperly marketed orthopedic products for indications that were not approved by the U.S. Food and Drug Administration. While drugs and medical devices are often prescribed “off-label”, at doctors’ discretion, it is illegal for pharmaceutical and medical device companies to market the products for those “off-label” purposes.